China's First IGF-1R Monoclonal Antibody: Innovent Announces NMPA Approval Of SYCUME® For The Treatment Of Thyroid Eye Disease
SAN FRANCISCO and SUZHOU, China, March 14, 2025 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutic ...
Biohybrid robots at the gym? It might make them stronger, Chinese study finds
Researchers built a bot with living tissue. Electrical and mechanical ‘training’ during growth nearly doubled muscle ...